Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E. Coli Nissle 1917 for Infection Prophylaxis in Infants
NCT02802059Phase 3Completed
- Sponsor
- Ardeypharm
- Start
- Oct 2015
- Primary completion
- Oct 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 2
01
Overview
A Phase 3 trial of escherichia coli nissle 1917 in bacterial infection, viral infection, sponsored by Ardeypharm. Started Oct 2015; status: completed.
02
Drugs
escherichia coli nissle 1917
03
Conditions
bacterial infectionviral infection
Beyond the preview
Go deeper on NCT02802059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802059.